Gold edges higher on softer oil; Fed rate outlook in focus
Gold prices edged higher on Monday as softer oil prices offered support, while investors assessed the chances of a Federal Reserve interest rate hike later this year and looked for fresh signals on the U.S. central bank’s policy trajectory.
Brendon Thorne | Bloomberg | Getty Images
Gold prices edged higher on Monday as softer oil prices offered support,
» Read more about: Gold edges higher on softer oil; Fed rate outlook in focus »
Read More[10/19 Gold Market Analysis] Despite AI stock sell-offs and $100 oil, gold holds firm in the $4,180 range | Battle in the upper half of the range
Last weekend (10/16), gold traded in a $51 range between $4,147 and $4,198 amid risk-off factors including a sharp drop in US stocks and rising oil prices. The week started with an orderly rise from $4,176 to $4,185. Here are this week’s key points, organized by charts and data.
📊 Yesterday’s (10/16) market data
💡 Terminology Note:
VIX is the ‘US stock fear index,’
[Big Losses in CFD] My New Strategy After Constant Defeat! Can I Recover My Losses by Buying the Dip in Gold and Silver?
[New Strategy for CFD Investing] Why I, Who Cannot Win at Short-Term Trading, Started Buying the Dip in Gold and Silver
Around September 10, 2026
I am currently managing my assets with a focus on stock investments, aiming to grow my initial capital of 7.5 million yen into 100 million yen.
Read MoreTech Stock Sell-Off: This Could Be the Most Powerful Reason to Buy Bonds Right Now
Key Points
-
After a yearlong rise in bond yields, now could be a good occasion to buy bonds to protect some of your portfolio from the risk of a stock market crash.
-
During the recent tech stock sell-off in October, Treasury yields dropped —
The Burst
Market Commentary: Shocking 2030 Trend Will Make Millionaires
What percentage of the US population is obese? Go on, hazard a guess. What do you think the figure is without looking it up?
According to Healthline, a little over 42% of the US population is clinically obese. And that figure is expected to balloon to 50% by 2030.
Read MoreThe Ivy
Is This Little-Known Health Innovation The Next Big Thing?
It’s hard to find the next big thing but Exact Sciences might be as close as any company is to it via its liquid biopsies, a transformative approach to diagnosing and monitoring various diseases by detecting signs of cancer, genetic anomalies, or other conditions in blood or other bodily fluids.
This technology has been particularly promising for cancer,
» Read more about: Is This Little-Known Health Innovation The Next Big Thing? »
Read More